These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15001473)

  • 1. An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line.
    Ghetie MA; Marches R; Kufert S; Vitetta ES
    Blood; 2004 Jul; 104(1):178-83. PubMed ID: 15001473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts.
    Ghetie MA; Crank M; Kufert S; Pop I; Vitetta E
    J Immunother; 2006; 29(5):536-44. PubMed ID: 16971809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
    Ghetie MA; Ghetie V; Vitetta ES
    Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors.
    O'Connor R; Liu C; Ferris CA; Guild BC; Teicher BA; Corvi C; Liu Y; Arceci RJ; Goldmacher VS; Lambert JM; Blättler WA
    Blood; 1995 Dec; 86(11):4286-94. PubMed ID: 7492789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and purification of two anti-CD19 single chain Fv fragments for targeting of liposomes to CD19-expressing cells.
    Cheng WW; Das D; Suresh M; Allen TM
    Biochim Biophys Acta; 2007 Jan; 1768(1):21-9. PubMed ID: 17046711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-Depletion-Induced Membrane Repair Carries a Raft Conformer of P-Glycoprotein to the Cell Surface, Indicating Enhanced Cholesterol Trafficking in MDR Cells, Which Makes Them Resistant to Cholesterol Modifications.
    Gutay-Tóth Z; Gellen G; Doan M; Eliason JF; Vincze J; Szente L; Fenyvesi F; Goda K; Vecsernyés M; Szabó G; Bacso Z
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein.
    Pop I; Pop L; Vitetta ES; Ghetie MA
    Oncol Rep; 2008 Apr; 19(4):889-95. PubMed ID: 18357372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
    Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
    Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ecto-5'-nucleotidase promotes P-glycoprotein expression in renal epithelial cells.
    Ledoux S; Leroy C; Siegfried G; Prie D; Moullier P; Friedlander G
    Kidney Int; 1997 Oct; 52(4):953-61. PubMed ID: 9328934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities.
    Bucher K; Besse CA; Kamau SW; Wunderli-Allenspach H; Krämer SD
    Pharm Res; 2005 Mar; 22(3):449-57. PubMed ID: 15835751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells.
    Kamau SW; Krämer SD; Günthert M; Wunderli-Allenspach H
    In Vitro Cell Dev Biol Anim; 2005; 41(7):207-16. PubMed ID: 16223335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma.
    Savas B; Cole SP; Tsuruo T; Pross HF
    J Clin Immunol; 1996 Nov; 16(6):348-57. PubMed ID: 8946280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
    Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
    Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
    Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody.
    Vallera DA; Elson M; Brechbiel MW; Dusenbery KE; Burns LJ; Jaszcz WB; Ramsay NK; Panoskaltsis-Mortar A; Kuroki DW; Wagner JE; Vitetta ES; Kersey JH
    Cancer Biother Radiopharm; 2004 Feb; 19(1):11-23. PubMed ID: 15068607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
    Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
    Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.